Synthesis, characterization and biological activity of Schiff bases derived from metronidazole

被引:31
作者
Saadeh, Haythem A. [1 ]
Abu Shaireh, Eman A. [1 ]
Mosleh, Ibrahim M. [2 ]
Al-Bakri, Amal G. [3 ]
Mubarak, Mohammad S. [1 ]
机构
[1] Univ Jordan, Dept Chem, Amman 11942, Jordan
[2] Univ Jordan, Dept Biol Sci, Amman 11942, Jordan
[3] Univ Jordan, Dept Pharmaceut & Pharmaceut Technol, Fac Pharm, Amman 11942, Jordan
关键词
Metronidazole; Schiff bases; Antigiardial activity; DERIVATIVES; GIARDIA;
D O I
10.1007/s00044-011-9830-y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel Schiff bases; compounds 3a-j were prepared by reacting 1-(2-aminoethyl)-2-methyl-5-nitroimidazole dihydrochloride monohydrate (1) with different aldehydes. The structures of these compounds were confirmed through different spectroscopic methods such as H-1-NMR, C-13-NMR and mass spectrometry and also by elemental analyses. The prepared compounds were evaluated in vitro for their antigiardial, antibacterial and antifungal activities. Compounds 3h, 3b and 3d showed remarkable antigiardial activities and were found to be more active than metronidazole with IC50 of 0.83, 1.36 and 1.83 mu M, respectively. Other compounds also exhibited antigiardial activity and were as good as or even more potent than metronidazole. Some of the newly synthesized Schiff bases exhibited more antifungal activities than the parent drug. In addition, a few of the prepared compounds exhibited modest antibacterial activity but were not as active as metronidazole.
引用
收藏
页码:2969 / 2974
页数:6
相关论文
共 21 条
[1]  
Abu-Shaireh EAM, 2009, European Patent, Patent No. [09250251.7-2117, 0925025172117]
[2]  
Abu-Shaireh EAM, 2009, Eur Pat Appl EP, Patent No. [2985394 A2, 2985394]
[3]  
Al-Zghoul KH, 2005, HETEROCYCLES, V65, P2937
[4]   KILLING OF GIARDIA-LAMBLIA BY CRYPTDINS AND CATIONIC NEUTROPHIL PEPTIDES [J].
ALEY, SB ;
ZIMMERMAN, M ;
HETSKO, M ;
SELSTED, ME ;
GILLIN, FD .
INFECTION AND IMMUNITY, 1994, 62 (12) :5397-5403
[5]   Synthesis and anti-Helicobacter pylori properties of NO-donor/metronidazole hybrids and related compounds [J].
Bertinaria, M ;
Galli, U ;
Sorba, G ;
Fruttero, R ;
Gasco, A ;
Brenciaglia, MI ;
Scaltrito, MM ;
Dubini, F .
DRUG DEVELOPMENT RESEARCH, 2003, 60 (03) :225-239
[6]   Novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. A structure-activity relationship investigation [J].
De Martino, G ;
La Regina, G ;
Di Pasquali, A ;
Ragno, R ;
Bergamini, A ;
Ciaprini, C ;
Sinistro, A ;
Maga, G ;
Crespan, E ;
Artico, M ;
Silvestri, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (13) :4378-4388
[7]   Genotoxic effects of metronidazole [J].
Elizondo, G ;
Gonsebatt, ME ;
Salazar, AM ;
Lares, IL ;
Santiago, P ;
Herrera, J ;
Hong, E ;
OstroskyWegman, P .
MUTATION RESEARCH-GENETIC TOXICOLOGY, 1996, 370 (02) :75-80
[8]   Cd(II) and Cu(II) complexes of polydentate Schiff base ligands: synthesis, characterization, properties and biological activity [J].
Golcu, A ;
Tumer, M ;
Demirelli, H ;
Wheatley, RA .
INORGANICA CHIMICA ACTA, 2005, 358 (06) :1785-1797
[9]   REACTIONS OF NITROIMIDAZOLES - NUCLEOPHILIC-SUBSTITUTION OF THE NITRO-GROUP [J].
GOLDMAN, P ;
WUEST, JD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1981, 103 (20) :6224-6226
[10]   5-Nitroimidazole derivatives as possible antibacterial and antifungal agents [J].
Günay, NS ;
Capan, G ;
Ulusoy, N ;
Ergenç, N ;
Ötük, G ;
Kaya, D .
FARMACO, 1999, 54 (11-12) :826-831